Procter & Gamble Forecast, price target & analysts
Procter & Gamble Target price 2025 - Analyst rating & recommendation
Procter & Gamble Classifications & Recommendation:
Procter & Gamble Price Target
| Target Price | $183.60 |
| Price | $158.63 |
| Potential | 15.74% |
| Number of Estimates | 28 |
| 28 Analysts have issued a price target Procter & Gamble 2026 . The average Procter & Gamble target price is $183.60. This is 15.74% higher than the current stock price. The highest price target is $199.50 25.76% , the lowest is $145.66 8.17% . | |
| A rating was issued by 35 analysts: 25 Analysts recommend Procter & Gamble to buy, 10 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Procter & Gamble stock has an average upside potential 2026 of 15.74% . Most analysts recommend the Procter & Gamble stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2032
26 Analysts have issued a sales forecast Procter & Gamble 2025 . The average Procter & Gamble sales estimate is $86.7b . This is 3.31% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $88.7b 5.74% , the lowest is $82.0b 2.25% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $84.0b | 2.48% |
|---|---|---|
| 2025 | $86.7b | 3.17% |
| 2026 | $89.1b | 2.75% |
| 2027 | $92.3b | 3.60% |
| 2028 | $96.3b | 4.32% |
| 2029 | $99.7b | 3.60% |
| 2030 | $103b | 3.71% |
| 2031 | $107b | 3.29% |
| 2032 | $111b | 3.70% |
24 Analysts have issued an Procter & Gamble EBITDA forecast 2025. The average Procter & Gamble EBITDA estimate is $24.1b . This is 3.87% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $26.2b 12.62% , the lowest is $22.0b 5.23% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $23.2b | 9.53% |
|---|---|---|
| 2025 | $24.1b | 4.02% |
| 2026 | $25.0b | 3.51% |
| 2027 | $26.3b | 5.47% |
| 2028 | $27.5b | 4.32% |
| 2029 | $28.3b | 2.89% |
| 2030 | $29.4b | 3.90% |
| 2031 | $29.9b | 1.71% |
| 2032 | $31.0b | 3.70% |
EBITDA Margin
| 2024 | 27.59% | 6.88% |
|---|---|---|
| 2025 | 27.82% | 0.84% |
| 2026 | 28.02% | 0.72% |
| 2027 | 28.53% | 1.82% |
| 2028 | 28.53% | 0.00% |
| 2029 | 28.33% | 0.70% |
| 2030 | 28.38% | 0.18% |
| 2031 | 27.95% | 1.52% |
| 2032 | 27.95% | 0.00% |
27 Procter & Gamble Analysts have issued a net profit forecast 2025. The average Procter & Gamble net profit estimate is $16.3b . This is 7.51% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $16.8b 10.42% , the lowest is $15.2b 0.27% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $14.6b | 1.56% |
|---|---|---|
| 2025 | $16.3b | 12.01% |
| 2026 | $16.9b | 3.27% |
| 2027 | $17.9b | 6.24% |
| 2028 | $18.9b | 5.35% |
| 2029 | $19.7b | 4.35% |
| 2030 | $20.7b | 5.21% |
| 2031 | $21.7b | 4.66% |
| 2032 | $22.9b | 5.67% |
Net Margin
| 2024 | 17.37% | 0.90% |
|---|---|---|
| 2025 | 18.86% | 8.60% |
| 2026 | 18.95% | 0.48% |
| 2027 | 19.43% | 2.53% |
| 2028 | 19.63% | 1.03% |
| 2029 | 19.77% | 0.71% |
| 2030 | 20.05% | 1.42% |
| 2031 | 20.32% | 1.35% |
| 2032 | 20.71% | 1.92% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
27 Analysts have issued a Procter & Gamble forecast for earnings per share. The average Procter & Gamble EPS is $6.97 . This is 12.42% higher than earnings per share in the financial year 2024. The highest EPS forecast is $7.16 15.48% , the lowest is $6.47 4.35% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $5.90 | 2.08% |
|---|---|---|
| 2025 | $6.97 | 18.14% |
| 2026 | $7.20 | 3.30% |
| 2027 | $7.65 | 6.25% |
| 2028 | $8.06 | 5.36% |
| 2029 | $8.41 | 4.34% |
| 2030 | $8.85 | 5.23% |
| 2031 | $9.26 | 4.63% |
| 2032 | $9.79 | 5.72% |
P/E ratio
| Current | 25.59 | 8.76% |
|---|---|---|
| 2025 | 22.75 | 11.08% |
| 2026 | 22.03 | 3.16% |
| 2027 | 20.74 | 5.86% |
| 2028 | 19.68 | 5.11% |
| 2029 | 18.86 | 4.17% |
| 2030 | 17.93 | 4.93% |
| 2031 | 17.13 | 4.46% |
| 2032 | 16.21 | 5.37% |
Based on analysts' sales estimates for 2025, the Procter & Gamble stock is valued at an EV/Sales of 4.58 and an P/S ratio of 4.29 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 4.73 | 5.78% |
|---|---|---|
| 2025 | 4.58 | 3.21% |
| 2026 | 4.46 | 2.68% |
| 2027 | 4.30 | 3.47% |
| 2028 | 4.12 | 4.14% |
| 2029 | 3.98 | 3.47% |
| 2030 | 3.84 | 3.57% |
| 2031 | 3.72 | 3.19% |
| 2032 | 3.58 | 3.57% |
P/S ratio
| Current | 4.43 | 6.20% |
|---|---|---|
| 2025 | 4.29 | 3.20% |
| 2026 | 4.17 | 2.68% |
| 2027 | 4.03 | 3.47% |
| 2028 | 3.86 | 4.14% |
| 2029 | 3.73 | 3.47% |
| 2030 | 3.60 | 3.57% |
| 2031 | 3.48 | 3.19% |
| 2032 | 3.36 | 3.57% |
Procter & Gamble...
Current Procter & Gamble Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Jun 03 2025 |
| Piper Sandler |
Neutral
➜
Neutral
|
Unchanged | May 05 2025 |
| B of A Securities |
Buy
➜
Buy
|
Unchanged | Apr 25 2025 |
| Raymond James |
Outperform
➜
Outperform
|
Unchanged | Apr 25 2025 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Apr 25 2025 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Apr 25 2025 |
| RBC Capital |
Sector Perform
➜
Outperform
|
Upgrade | Apr 25 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Jun 03 2025 |
|
Unchanged
Piper Sandler:
Neutral
➜
Neutral
|
May 05 2025 |
|
Unchanged
B of A Securities:
Buy
➜
Buy
|
Apr 25 2025 |
|
Unchanged
Raymond James:
Outperform
➜
Outperform
|
Apr 25 2025 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Apr 25 2025 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Apr 25 2025 |
|
Upgrade
RBC Capital:
Sector Perform
➜
Outperform
|
Apr 25 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
